# Dell Technologies timeline

entity: /record/dell.md  
id: ent_dell  


## undated

- undated | cik | 0001571996 | valid | [clm_2976B95AC4C5](/claim/clm_2976B95AC4C5.md)
- undated | sic_industry | Electronic Computers (3571) | valid | [clm_3E9C976F0E59](/claim/clm_3E9C976F0E59.md)
- undated | ticker | DELL | valid | [clm_66322BA0887A](/claim/clm_66322BA0887A.md)
- undated | state_of_incorporation | TX | valid | [clm_73F3BB53073C](/claim/clm_73F3BB53073C.md)
- undated | listed_on | NYSE | valid | [clm_AD80D946E438](/claim/clm_AD80D946E438.md)
- undated | fiscal_year_end | 01-29 | valid | [clm_D49437A3B548](/claim/clm_D49437A3B548.md)

## 2013

- 2013-07-24 to 2016-01-14 | registrant_name | Denali Holding Inc. | superseded | [clm_24965D0311B2](/claim/clm_24965D0311B2.md)

## 2015

- 2015-01-30 to 2016-01-29 | operating_income | -316,000,000 United States dollar | superseded | [clm_44223EBEDBA6](/claim/clm_44223EBEDBA6.md)
- 2015-01-30 to 2016-01-29 | revenue | 54,142,000,000 United States dollar | superseded | [clm_C3875A3F70E5](/claim/clm_C3875A3F70E5.md)
- 2015-01-30 to 2016-01-29 | research_and_development | 920,000,000 United States dollar | superseded | [clm_D0C6C7A9CAE0](/claim/clm_D0C6C7A9CAE0.md)
- 2015-01-30 to 2015-05-01 | cash_and_equivalents | 5,398,000,000 United States dollar | superseded | [clm_DF5F8C4D2EC0](/claim/clm_DF5F8C4D2EC0.md)
- 2015-01-30 to 2016-01-29 | net_income | -1,221,000,000 United States dollar | superseded | [clm_E3ADC07916BE](/claim/clm_E3ADC07916BE.md)
- 2015-05-01 to 2015-07-31 | quarterly_operating_income | -335,000,000 United States dollar | superseded | [clm_202FD8816022](/claim/clm_202FD8816022.md)
- 2015-05-01 to 2015-07-31 | quarterly_research_and_development | 325,000,000 United States dollar | superseded | [clm_56432C18D710](/claim/clm_56432C18D710.md)
- 2015-05-01 to 2015-07-31 | quarterly_net_income | -504,000,000 United States dollar | superseded | [clm_8046A3541E4C](/claim/clm_8046A3541E4C.md)
- 2015-05-01 to 2015-07-31 | quarterly_revenue | 12,838,000,000 United States dollar | superseded | [clm_C60748DFCA9B](/claim/clm_C60748DFCA9B.md)
- 2015-05-01 to 2015-07-31 | cash_and_equivalents | 4,774,000,000 United States dollar | superseded | [clm_FC8A9056C691](/claim/clm_FC8A9056C691.md)
- 2015-07-31 to 2015-10-30 | quarterly_research_and_development | 250,000,000 United States dollar | superseded | [clm_2FC85A9ADD83](/claim/clm_2FC85A9ADD83.md)
- 2015-07-31 to 2015-10-30 | cash_and_equivalents | 5,999,000,000 United States dollar | superseded | [clm_45434E6A8375](/claim/clm_45434E6A8375.md)
- 2015-07-31 to 2015-10-30 | quarterly_operating_income | -103,000,000 United States dollar | superseded | [clm_7BA7D633B317](/claim/clm_7BA7D633B317.md)
- 2015-07-31 to 2015-10-30 | quarterly_revenue | 12,975,000,000 United States dollar | superseded | [clm_8CD6C053FAC3](/claim/clm_8CD6C053FAC3.md)
- 2015-07-31 to 2015-10-30 | quarterly_net_income | -265,000,000 United States dollar | superseded | [clm_C68838EF84A0](/claim/clm_C68838EF84A0.md)
- 2015-10-30 to 2016-04-29 | quarterly_operating_income | -78,000,000 United States dollar | superseded | [clm_2E2ED1F6AF5B](/claim/clm_2E2ED1F6AF5B.md)
- 2015-10-30 to 2016-01-29 | cash_and_equivalents | 5,654,000,000 United States dollar | superseded | [clm_8263274CF805](/claim/clm_8263274CF805.md)
- 2015-10-30 to 2016-04-29 | quarterly_net_income | -180,000,000 United States dollar | superseded | [clm_83E0E28BFC08](/claim/clm_83E0E28BFC08.md)
- 2015-10-30 to 2016-04-29 | quarterly_revenue | 12,674,000,000 United States dollar | superseded | [clm_CADDF8FC0690](/claim/clm_CADDF8FC0690.md)
- 2015-10-30 to 2016-04-29 | quarterly_research_and_development | 267,000,000 United States dollar | superseded | [clm_F798E954946F](/claim/clm_F798E954946F.md)

## 2016

- 2016-01-14 | registrant_name | Dell Technologies Inc. | valid | [clm_29CA998A767E](/claim/clm_29CA998A767E.md)
- 2016-01-29 to 2017-02-03 | operating_income | -514,000,000 United States dollar | superseded | [clm_0BA3701EEDDD](/claim/clm_0BA3701EEDDD.md)
- 2016-01-29 to 2017-02-03 | revenue | 50,911,000,000 United States dollar | superseded | [clm_213223459AA3](/claim/clm_213223459AA3.md)
- 2016-01-29 to 2017-02-03 | net_income | -1,104,000,000 United States dollar | superseded | [clm_2AF59C47F0B0](/claim/clm_2AF59C47F0B0.md)
- 2016-01-29 to 2016-04-29 | cash_and_equivalents | 6,322,000,000 United States dollar | superseded | [clm_5753747CCE0E](/claim/clm_5753747CCE0E.md)
- 2016-01-29 to 2016-04-29 | total_equity | 1,466,000,000 United States dollar | superseded | [clm_833C04C6E44F](/claim/clm_833C04C6E44F.md)
- 2016-01-29 to 2017-02-03 | research_and_development | 1,051,000,000 United States dollar | superseded | [clm_BEB871B7E2D6](/claim/clm_BEB871B7E2D6.md)
- 2016-01-29 to 2016-04-29 | total_assets | 45,122,000,000 United States dollar | superseded | [clm_EEBC82A245F4](/claim/clm_EEBC82A245F4.md)
- 2016-04-01 | x_username | DellTech | unverified | [clm_6A7876A6DFB0](/claim/clm_6A7876A6DFB0.md)
- 2016-04-29 to 2016-07-29 | cash_and_equivalents | 6,139,000,000 United States dollar | superseded | [clm_3649C902ECCC](/claim/clm_3649C902ECCC.md)
- 2016-04-29 to 2016-07-29 | quarterly_operating_income | -161,000,000 United States dollar | superseded | [clm_5F5DD3490EB0](/claim/clm_5F5DD3490EB0.md)
- 2016-04-29 to 2016-07-29 | quarterly_net_income | 55,000,000 United States dollar | superseded | [clm_8366A3081EB0](/claim/clm_8366A3081EB0.md)
- 2016-04-29 to 2016-07-29 | quarterly_revenue | 12,534,000,000 United States dollar | superseded | [clm_859DBF8BBC6D](/claim/clm_859DBF8BBC6D.md)
- 2016-04-29 to 2016-07-29 | quarterly_research_and_development | 333,000,000 United States dollar | superseded | [clm_936C247E7AE2](/claim/clm_936C247E7AE2.md)
- 2016-04-29 to 2016-07-29 | total_assets | 43,879,000,000 United States dollar | superseded | [clm_A8C4DF8CF7EC](/claim/clm_A8C4DF8CF7EC.md)
- 2016-04-29 to 2016-07-29 | total_equity | 1,442,000,000 United States dollar | superseded | [clm_B2FF56899E3D](/claim/clm_B2FF56899E3D.md)
- 2016-07-29 to 2016-10-28 | quarterly_research_and_development | 246,000,000 United States dollar | superseded | [clm_4080ABBDC9DF](/claim/clm_4080ABBDC9DF.md)
- 2016-07-29 to 2016-10-28 | cash_and_equivalents | 7,226,000,000 United States dollar | superseded | [clm_4452B8D18E47](/claim/clm_4452B8D18E47.md)
- 2016-07-29 to 2016-10-28 | quarterly_net_income | 573,000,000 United States dollar | superseded | [clm_60E52E8B8F0E](/claim/clm_60E52E8B8F0E.md)
- 2016-07-29 to 2016-10-28 | quarterly_operating_income | 63,000,000 United States dollar | superseded | [clm_7FCD391DA168](/claim/clm_7FCD391DA168.md)
- 2016-07-29 to 2016-10-28 | total_equity | 2,065,000,000 United States dollar | superseded | [clm_8FE5B99AEFD2](/claim/clm_8FE5B99AEFD2.md)
- 2016-07-29 to 2016-10-28 | quarterly_revenue | 13,050,000,000 United States dollar | superseded | [clm_D286888EF580](/claim/clm_D286888EF580.md)
- 2016-07-29 to 2016-10-28 | total_assets | 68,916,000,000 United States dollar | superseded | [clm_E4D058932AA4](/claim/clm_E4D058932AA4.md)

## undated

- undated | website | http://www.delltechnologies.com/ | unverified | [clm_13034B592C65](/claim/clm_13034B592C65.md)
- undated | legal_form | corporation | unverified | [clm_536D7D3253AF](/claim/clm_536D7D3253AF.md)
- undated | member_of | Wi-Fi Alliance | unverified | [clm_7F947E9A4A2B](/claim/clm_7F947E9A4A2B.md)
- undated | owned_by | Michael Dell | unverified | [clm_9BBA517631D8](/claim/clm_9BBA517631D8.md)

## 2016

- 2016-10-28 to 2017-05-05 | quarterly_net_income | -2,064,000,000 United States dollar | superseded | [clm_0E29C25A4443](/claim/clm_0E29C25A4443.md)
- 2016-10-28 to 2017-05-05 | quarterly_research_and_development | 855,000,000 United States dollar | superseded | [clm_1BA536EA4276](/claim/clm_1BA536EA4276.md)
- 2016-10-28 to 2017-02-03 | cash_and_equivalents | 8,822,000,000 United States dollar | superseded | [clm_344921D8CD5D](/claim/clm_344921D8CD5D.md)
- 2016-10-28 to 2017-05-05 | quarterly_revenue | 16,247,000,000 United States dollar | superseded | [clm_5498572B53C0](/claim/clm_5498572B53C0.md)
- 2016-10-28 to 2017-05-05 | quarterly_operating_income | -1,512,000,000 United States dollar | superseded | [clm_90EC006239B3](/claim/clm_90EC006239B3.md)
- 2016-10-28 to 2017-02-03 | total_assets | 125,632,000,000 United States dollar | superseded | [clm_C2E87923D21C](/claim/clm_C2E87923D21C.md)
- 2016-10-28 to 2017-02-03 | total_equity | 13,880,000,000 United States dollar | superseded | [clm_D7714197C7B3](/claim/clm_D7714197C7B3.md)

## 2017

- 2017-02-03 to 2018-02-02 | revenue | 61,642,000,000 United States dollar | superseded | [clm_1177B58CD762](/claim/clm_1177B58CD762.md)
- 2017-02-03 to 2017-05-05 | total_equity | 13,243,000,000 United States dollar | superseded | [clm_53DED92A58B3](/claim/clm_53DED92A58B3.md)
- 2017-02-03 to 2017-05-05 | total_assets | 118,206,000,000 United States dollar | superseded | [clm_69055ED95A4F](/claim/clm_69055ED95A4F.md)
- 2017-02-03 to 2017-05-05 | cash_and_equivalents | 9,474,000,000 United States dollar | superseded | [clm_783870B5D74D](/claim/clm_783870B5D74D.md)
- 2017-02-03 to 2018-02-02 | operating_income | -3,252,000,000 United States dollar | superseded | [clm_8CAC96C58C9C](/claim/clm_8CAC96C58C9C.md)
- 2017-02-03 to 2018-02-02 | net_income | -1,672,000,000 United States dollar | superseded | [clm_DD4FEECCDE58](/claim/clm_DD4FEECCDE58.md)
- 2017-02-03 to 2018-02-02 | research_and_development | 2,636,000,000 United States dollar | superseded | [clm_E040AD7FFD57](/claim/clm_E040AD7FFD57.md)
- 2017-05-05 to 2017-08-04 | total_assets | 116,040,000,000 United States dollar | superseded | [clm_047A5A16D0D9](/claim/clm_047A5A16D0D9.md)
- 2017-05-05 to 2017-08-04 | total_equity | 11,532,000,000 United States dollar | superseded | [clm_28C6FD89AE60](/claim/clm_28C6FD89AE60.md)
- 2017-05-05 to 2017-08-04 | cash_and_equivalents | 9,554,000,000 United States dollar | superseded | [clm_5AEA62961F1B](/claim/clm_5AEA62961F1B.md)
- 2017-05-05 to 2017-08-04 | quarterly_net_income | -1,334,000,000 United States dollar | superseded | [clm_78A295436D9A](/claim/clm_78A295436D9A.md)
- 2017-05-05 to 2017-08-04 | quarterly_revenue | 17,816,000,000 United States dollar | superseded | [clm_7AEA89B03B3E](/claim/clm_7AEA89B03B3E.md)
- 2017-05-05 to 2017-08-04 | quarterly_research_and_development | 1,133,000,000 United States dollar | superseded | [clm_82E411DD7282](/claim/clm_82E411DD7282.md)
- 2017-05-05 to 2017-08-04 | quarterly_operating_income | -1,500,000,000 United States dollar | superseded | [clm_BDA9592B912F](/claim/clm_BDA9592B912F.md)
- 2017-08-04 to 2017-11-03 | total_equity | 10,947,000,000 United States dollar | superseded | [clm_4274203D1B94](/claim/clm_4274203D1B94.md)
- 2017-08-04 to 2017-11-03 | quarterly_operating_income | -979,000,000 United States dollar | superseded | [clm_48A2A52BB2AC](/claim/clm_48A2A52BB2AC.md)
- 2017-08-04 to 2017-11-03 | quarterly_net_income | -946,000,000 United States dollar | superseded | [clm_792102B27715](/claim/clm_792102B27715.md)
- 2017-08-04 to 2017-11-03 | quarterly_revenue | 19,521,000,000 United States dollar | superseded | [clm_862F5093FE88](/claim/clm_862F5093FE88.md)
- 2017-08-04 to 2017-11-03 | total_assets | 117,494,000,000 United States dollar | superseded | [clm_8CBC07E9F58B](/claim/clm_8CBC07E9F58B.md)
- 2017-08-04 to 2017-11-03 | cash_and_equivalents | 9,213,000,000 United States dollar | superseded | [clm_95ED875B487B](/claim/clm_95ED875B487B.md)
- 2017-08-04 to 2017-11-03 | quarterly_research_and_development | 1,093,000,000 United States dollar | superseded | [clm_E7DDC3590943](/claim/clm_E7DDC3590943.md)
- 2017-11-03 to 2018-02-02 | total_equity | 9,519,000,000 United States dollar | superseded | [clm_08FF95259DF7](/claim/clm_08FF95259DF7.md)
- 2017-11-03 to 2018-05-04 | quarterly_revenue | 19,556,000,000 United States dollar | superseded | [clm_32BEB41D1CD8](/claim/clm_32BEB41D1CD8.md)
- 2017-11-03 to 2018-02-02 | total_assets | 118,394,000,000 United States dollar | superseded | [clm_3CBD239FA3CC](/claim/clm_3CBD239FA3CC.md)
- 2017-11-03 to 2018-05-04 | quarterly_net_income | -937,000,000 United States dollar | superseded | [clm_5B7823DAD397](/claim/clm_5B7823DAD397.md)
- 2017-11-03 to 2018-05-04 | quarterly_operating_income | -533,000,000 United States dollar | superseded | [clm_85F193726EDC](/claim/clm_85F193726EDC.md)
- 2017-11-03 to 2018-02-02 | cash_and_equivalents | 11,706,000,000 United States dollar | superseded | [clm_B4B2BA4EA84F](/claim/clm_B4B2BA4EA84F.md)
- 2017-11-03 to 2018-05-04 | quarterly_research_and_development | 1,071,000,000 United States dollar | superseded | [clm_E5678059BA51](/claim/clm_E5678059BA51.md)

## 2018

- 2018-02-02 to 2018-05-04 | total_equity | 9,326,000,000 United States dollar | superseded | [clm_059031FD39F4](/claim/clm_059031FD39F4.md)
- 2018-02-02 to 2019-02-01 | revenue | 79,040,000,000 United States dollar | superseded | [clm_060FB96AB46D](/claim/clm_060FB96AB46D.md)
- 2018-02-02 to 2018-05-04 | total_assets | 122,281,000,000 United States dollar | superseded | [clm_0A68CBB24118](/claim/clm_0A68CBB24118.md)
- 2018-02-02 to 2019-02-01 | operating_income | -3,333,000,000 United States dollar | superseded | [clm_B43D51A3BDC3](/claim/clm_B43D51A3BDC3.md)
- 2018-02-02 to 2018-05-04 | cash_and_equivalents | 13,942,000,000 United States dollar | superseded | [clm_CDBB0E60B2DA](/claim/clm_CDBB0E60B2DA.md)
- 2018-02-02 to 2019-02-01 | net_income | -3,728,000,000 United States dollar | superseded | [clm_E17763E114D9](/claim/clm_E17763E114D9.md)
- 2018-02-02 to 2019-02-01 | research_and_development | 4,384,000,000 United States dollar | superseded | [clm_F6628A71DD48](/claim/clm_F6628A71DD48.md)
- 2018-05-04 to 2018-08-03 | quarterly_revenue | 21,356,000,000 United States dollar | superseded | [clm_0CFC6ACAB1EB](/claim/clm_0CFC6ACAB1EB.md)
- 2018-05-04 to 2018-08-03 | quarterly_research_and_development | 1,087,000,000 United States dollar | superseded | [clm_2B8F3E604949](/claim/clm_2B8F3E604949.md)
- 2018-05-04 to 2018-08-03 | total_equity | 10,485,000,000 United States dollar | superseded | [clm_5834ED012894](/claim/clm_5834ED012894.md)
- 2018-05-04 to 2018-08-03 | total_assets | 123,217,000,000 United States dollar | superseded | [clm_5F27727B00D4](/claim/clm_5F27727B00D4.md)
- 2018-05-04 to 2018-08-03 | quarterly_net_income | -636,000,000 United States dollar | superseded | [clm_7D36D07418EE](/claim/clm_7D36D07418EE.md)
- 2018-05-04 to 2018-08-03 | quarterly_operating_income | -153,000,000 United States dollar | superseded | [clm_ADC82AEB3F94](/claim/clm_ADC82AEB3F94.md)
- 2018-05-04 to 2018-08-03 | cash_and_equivalents | 15,324,000,000 United States dollar | superseded | [clm_D6FD224DBF61](/claim/clm_D6FD224DBF61.md)
- 2018-08-03 to 2018-11-02 | cash_and_equivalents | 15,312,000,000 United States dollar | superseded | [clm_039DFE94E50C](/claim/clm_039DFE94E50C.md)
- 2018-08-03 to 2018-11-02 | total_assets | 123,381,000,000 United States dollar | superseded | [clm_262AE6C6D937](/claim/clm_262AE6C6D937.md)
- 2018-08-03 to 2018-11-02 | quarterly_research_and_development | 1,175,000,000 United States dollar | superseded | [clm_50B7B7CA7CFA](/claim/clm_50B7B7CA7CFA.md)
- 2018-08-03 to 2018-11-02 | quarterly_net_income | -499,000,000 United States dollar | superseded | [clm_6B2B286041D4](/claim/clm_6B2B286041D4.md)
- 2018-08-03 to 2018-11-02 | quarterly_revenue | 22,942,000,000 United States dollar | superseded | [clm_C00248555011](/claim/clm_C00248555011.md)
- 2018-08-03 to 2018-11-02 | total_equity | 8,563,000,000 United States dollar | superseded | [clm_D1D955D8C719](/claim/clm_D1D955D8C719.md)
- 2018-08-03 to 2018-11-02 | quarterly_operating_income | -13,000,000 United States dollar | superseded | [clm_DFABF860F6FF](/claim/clm_DFABF860F6FF.md)
- 2018-11-02 to 2019-02-01 | cash_and_equivalents | 15,152,000,000 United States dollar | superseded | [clm_4C7F1961C253](/claim/clm_4C7F1961C253.md)
- 2018-11-02 to 2019-05-03 | quarterly_operating_income | -356,000,000 United States dollar | superseded | [clm_77963BE34712](/claim/clm_77963BE34712.md)
- 2018-11-02 to 2019-05-03 | quarterly_revenue | 22,482,000,000 United States dollar | superseded | [clm_7B5469EC3AD7](/claim/clm_7B5469EC3AD7.md)
- 2018-11-02 to 2019-02-01 | total_equity | 7,592,000,000 United States dollar | superseded | [clm_86DE920F1C1C](/claim/clm_86DE920F1C1C.md)
- 2018-11-02 to 2019-05-03 | quarterly_research_and_development | 1,140,000,000 United States dollar | superseded | [clm_9668FB87D980](/claim/clm_9668FB87D980.md)
- 2018-11-02 to 2019-02-01 | total_assets | 121,241,000,000 United States dollar | superseded | [clm_BEFC36274AB1](/claim/clm_BEFC36274AB1.md)
- 2018-11-02 to 2019-05-03 | quarterly_net_income | -876,000,000 United States dollar | superseded | [clm_F2F5428A7003](/claim/clm_F2F5428A7003.md)

## 2019

- 2019-02-01 to 2019-05-03 | total_assets | 111,820,000,000 United States dollar | superseded | [clm_0806F4BCBFF5](/claim/clm_0806F4BCBFF5.md)
- 2019-02-01 to 2019-05-03 | cash_and_equivalents | 9,676,000,000 United States dollar | superseded | [clm_3B49DB63ADA5](/claim/clm_3B49DB63ADA5.md)
- 2019-02-01 to 2019-05-03 | total_equity | -5,765,000,000 United States dollar | superseded | [clm_935363360858](/claim/clm_935363360858.md)
- 2019-02-01 to 2020-01-31 | research_and_development | 4,604,000,000 United States dollar | superseded | [clm_A6478021C671](/claim/clm_A6478021C671.md)
- 2019-02-01 to 2020-01-31 | revenue | 90,621,000,000 United States dollar | superseded | [clm_AEDF91828C6A](/claim/clm_AEDF91828C6A.md)
- 2019-02-01 to 2020-01-31 | operating_income | -191,000,000 United States dollar | superseded | [clm_CF4F515EB983](/claim/clm_CF4F515EB983.md)
- 2019-02-01 to 2020-01-31 | net_income | -2,310,000,000 United States dollar | superseded | [clm_D80FDF29F41C](/claim/clm_D80FDF29F41C.md)
- 2019-05-03 to 2019-08-02 | quarterly_net_income | 293,000,000 United States dollar | superseded | [clm_0F983272056F](/claim/clm_0F983272056F.md)
- 2019-05-03 to 2019-08-02 | total_equity | -6,464,000,000 United States dollar | superseded | [clm_27914BC52532](/claim/clm_27914BC52532.md)
- 2019-05-03 to 2019-08-02 | quarterly_operating_income | 550,000,000 United States dollar | superseded | [clm_8B17B7763BB6](/claim/clm_8B17B7763BB6.md)
- 2019-05-03 to 2019-08-02 | quarterly_revenue | 21,908,000,000 United States dollar | superseded | [clm_9B97C76C01A7](/claim/clm_9B97C76C01A7.md)
- 2019-05-03 to 2019-08-02 | cash_and_equivalents | 9,040,000,000 United States dollar | superseded | [clm_9FE2C3AD3756](/claim/clm_9FE2C3AD3756.md)
- 2019-05-03 to 2019-08-02 | quarterly_research_and_development | 1,176,000,000 United States dollar | superseded | [clm_A2069618B55B](/claim/clm_A2069618B55B.md)
- 2019-05-03 to 2019-08-02 | total_assets | 109,892,000,000 United States dollar | superseded | [clm_F61F97F0248A](/claim/clm_F61F97F0248A.md)
- 2019-08-02 to 2019-11-01 | quarterly_operating_income | 519,000,000 United States dollar | superseded | [clm_07753A2935F7](/claim/clm_07753A2935F7.md)
- 2019-08-02 to 2019-11-01 | quarterly_net_income | 3,416,000,000 United States dollar | superseded | [clm_1651BFC947AE](/claim/clm_1651BFC947AE.md)
- 2019-08-02 to 2019-11-01 | quarterly_research_and_development | 1,229,000,000 United States dollar | superseded | [clm_1762DBE52657](/claim/clm_1762DBE52657.md)
- 2019-08-02 to 2019-11-01 | quarterly_revenue | 23,370,000,000 United States dollar | superseded | [clm_4B7F7CABCCD9](/claim/clm_4B7F7CABCCD9.md)
- 2019-08-02 to 2019-11-01 | total_equity | -2,449,000,000 United States dollar | superseded | [clm_7803C59F6EBB](/claim/clm_7803C59F6EBB.md)
- 2019-08-02 to 2019-11-01 | total_assets | 115,520,000,000 United States dollar | superseded | [clm_8DE152F59D1C](/claim/clm_8DE152F59D1C.md)
- 2019-08-02 to 2019-11-01 | cash_and_equivalents | 9,193,000,000 United States dollar | superseded | [clm_D76495CED604](/claim/clm_D76495CED604.md)
- 2019-11-01 to 2020-05-01 | quarterly_revenue | 22,844,000,000 United States dollar | superseded | [clm_0D59D863F07B](/claim/clm_0D59D863F07B.md)
- 2019-11-01 to 2020-05-01 | quarterly_net_income | 499,000,000 United States dollar | superseded | [clm_23810DBAB4A5](/claim/clm_23810DBAB4A5.md)
- 2019-11-01 to 2020-01-31 | total_assets | 116,814,000,000 United States dollar | superseded | [clm_4A9B67E057D2](/claim/clm_4A9B67E057D2.md)
- 2019-11-01 to 2020-01-31 | cash_and_equivalents | 8,555,000,000 United States dollar | superseded | [clm_56BF17B4D1EB](/claim/clm_56BF17B4D1EB.md)
- 2019-11-01 to 2020-05-01 | quarterly_research_and_development | 1,262,000,000 United States dollar | superseded | [clm_D712617CCDED](/claim/clm_D712617CCDED.md)
- 2019-11-01 to 2020-05-01 | quarterly_operating_income | 836,000,000 United States dollar | superseded | [clm_DC2EBA5377A9](/claim/clm_DC2EBA5377A9.md)
- 2019-11-01 to 2020-01-31 | total_equity | -1,804,000,000 United States dollar | superseded | [clm_DC88FFB9C4A4](/claim/clm_DC88FFB9C4A4.md)

## 2020

- 2020-01-31 to 2021-01-29 | net_income | 4,616,000,000 United States dollar | superseded | [clm_109176170392](/claim/clm_109176170392.md)
- 2020-01-31 to 2020-05-01 | total_equity | -1,574,000,000 United States dollar | superseded | [clm_3DC1A25817E4](/claim/clm_3DC1A25817E4.md)
- 2020-01-31 to 2021-01-29 | operating_income | 2,622,000,000 United States dollar | superseded | [clm_A833B8A21A23](/claim/clm_A833B8A21A23.md)
- 2020-01-31 to 2021-01-29 | research_and_development | 4,992,000,000 United States dollar | superseded | [clm_AFD0AFCBB324](/claim/clm_AFD0AFCBB324.md)
- 2020-01-31 to 2020-05-01 | total_assets | 118,861,000,000 United States dollar | superseded | [clm_BC2388102989](/claim/clm_BC2388102989.md)
- 2020-01-31 to 2020-05-01 | cash_and_equivalents | 9,302,000,000 United States dollar | superseded | [clm_BF994E18F704](/claim/clm_BF994E18F704.md)
- 2020-01-31 to 2021-01-29 | revenue | 92,154,000,000 United States dollar | superseded | [clm_CBB3434347B9](/claim/clm_CBB3434347B9.md)
- 2020-05-01 to 2020-07-31 | total_assets | 120,236,000,000 United States dollar | superseded | [clm_2C0443082E05](/claim/clm_2C0443082E05.md)
- 2020-05-01 to 2020-07-31 | cash_and_equivalents | 12,229,000,000 United States dollar | superseded | [clm_3AAACBA9316A](/claim/clm_3AAACBA9316A.md)
- 2020-05-01 to 2020-07-31 | quarterly_operating_income | 702,000,000 United States dollar | superseded | [clm_7B4F304F4C30](/claim/clm_7B4F304F4C30.md)
- 2020-05-01 to 2020-07-31 | quarterly_research_and_development | 1,265,000,000 United States dollar | superseded | [clm_80A6504C8D70](/claim/clm_80A6504C8D70.md)
- 2020-05-01 to 2020-07-31 | quarterly_revenue | 21,897,000,000 United States dollar | superseded | [clm_8C23E933F69D](/claim/clm_8C23E933F69D.md)
- 2020-05-01 to 2020-07-31 | quarterly_net_income | 143,000,000 United States dollar | superseded | [clm_CEFC33DE3323](/claim/clm_CEFC33DE3323.md)
- 2020-05-01 to 2020-07-31 | total_equity | -1,614,000,000 United States dollar | superseded | [clm_FE78DBD32D24](/claim/clm_FE78DBD32D24.md)
- 2020-07-31 to 2020-10-30 | total_equity | -419,000,000 United States dollar | superseded | [clm_01C951D8C1B5](/claim/clm_01C951D8C1B5.md)
- 2020-07-31 to 2020-10-30 | quarterly_net_income | 1,048,000,000 United States dollar | superseded | [clm_40CE5B3A3B0A](/claim/clm_40CE5B3A3B0A.md)
- 2020-07-31 to 2020-10-30 | quarterly_research_and_development | 1,259,000,000 United States dollar | superseded | [clm_B35228E76BF9](/claim/clm_B35228E76BF9.md)
- 2020-07-31 to 2020-10-30 | quarterly_revenue | 22,733,000,000 United States dollar | superseded | [clm_B44024CBD710](/claim/clm_B44024CBD710.md)
- 2020-07-31 to 2020-10-30 | quarterly_operating_income | 1,136,000,000 United States dollar | superseded | [clm_EA58343B317F](/claim/clm_EA58343B317F.md)
- 2020-07-31 to 2020-10-30 | cash_and_equivalents | 11,221,000,000 United States dollar | superseded | [clm_EFDDB16FDB42](/claim/clm_EFDDB16FDB42.md)
- 2020-07-31 to 2020-10-30 | total_assets | 121,276,000,000 United States dollar | superseded | [clm_F900809E9B01](/claim/clm_F900809E9B01.md)
- 2020-10-30 to 2021-01-29 | total_equity | 883,000,000 United States dollar | superseded | [clm_0FE21588AAFA](/claim/clm_0FE21588AAFA.md)
- 2020-10-30 to 2021-04-30 | quarterly_operating_income | 1,129,000,000 United States dollar | superseded | [clm_4B803BC85434](/claim/clm_4B803BC85434.md)
- 2020-10-30 to 2021-01-29 | total_assets | 118,948,000,000 United States dollar | superseded | [clm_6653770E7B70](/claim/clm_6653770E7B70.md)
- 2020-10-30 to 2021-04-30 | quarterly_research_and_development | 1,360,000,000 United States dollar | superseded | [clm_B9E52F0D3E02](/claim/clm_B9E52F0D3E02.md)
- 2020-10-30 to 2021-04-30 | quarterly_net_income | 832,000,000 United States dollar | superseded | [clm_CA4C2120CCB4](/claim/clm_CA4C2120CCB4.md)
- 2020-10-30 to 2021-04-30 | quarterly_revenue | 23,482,000,000 United States dollar | superseded | [clm_F45C0A14008B](/claim/clm_F45C0A14008B.md)
- 2020-10-30 to 2021-01-29 | cash_and_equivalents | 11,304,000,000 United States dollar | superseded | [clm_F9D8CAAA5132](/claim/clm_F9D8CAAA5132.md)

## 2021

- 2021-01-29 to 2021-04-30 | total_equity | 2,479,000,000 United States dollar | superseded | [clm_12EF254F5113](/claim/clm_12EF254F5113.md)
- 2021-01-29 to 2022-01-28 | operating_income | 5,144,000,000 United States dollar | superseded | [clm_15B0EF789543](/claim/clm_15B0EF789543.md)
- 2021-01-29 to 2022-01-28 | revenue | 94,224,000,000 United States dollar | superseded | [clm_27D822FE4910](/claim/clm_27D822FE4910.md)
- 2021-01-29 to 2021-04-30 | total_assets | 123,415,000,000 United States dollar | superseded | [clm_59389EAB55BE](/claim/clm_59389EAB55BE.md)
- 2021-01-29 to 2021-04-30 | cash_and_equivalents | 14,201,000,000 United States dollar | superseded | [clm_61D7AA65D6A0](/claim/clm_61D7AA65D6A0.md)
- 2021-01-29 to 2022-01-28 | net_income | 3,250,000,000 United States dollar | superseded | [clm_673803DD5C9C](/claim/clm_673803DD5C9C.md)
- 2021-01-29 to 2022-01-28 | research_and_development | 5,275,000,000 United States dollar | superseded | [clm_C9A3FB3973EC](/claim/clm_C9A3FB3973EC.md)
- 2021-04-30 to 2021-07-30 | quarterly_research_and_development | 1,323,000,000 United States dollar | superseded | [clm_2C1D7F846005](/claim/clm_2C1D7F846005.md)
- 2021-04-30 to 2021-07-30 | total_equity | 3,487,000,000 United States dollar | superseded | [clm_4394541F6B3F](/claim/clm_4394541F6B3F.md)
- 2021-04-30 to 2021-07-30 | total_assets | 121,752,000,000 United States dollar | superseded | [clm_77684C7810CB](/claim/clm_77684C7810CB.md)
- 2021-04-30 to 2021-07-30 | cash_and_equivalents | 14,244,000,000 United States dollar | superseded | [clm_A561E9A7D926](/claim/clm_A561E9A7D926.md)
- 2021-04-30 to 2021-07-30 | quarterly_net_income | 887,000,000 United States dollar | superseded | [clm_A79BF754F7AD](/claim/clm_A79BF754F7AD.md)
- 2021-04-30 to 2021-07-30 | quarterly_operating_income | 1,375,000,000 United States dollar | superseded | [clm_C9F673252622](/claim/clm_C9F673252622.md)
- 2021-04-30 to 2021-07-30 | quarterly_revenue | 24,487,000,000 United States dollar | superseded | [clm_D18DB1E5CB7B](/claim/clm_D18DB1E5CB7B.md)
- 2021-07-30 to 2021-10-29 | quarterly_operating_income | 1,372,000,000 United States dollar | superseded | [clm_53C0247588B7](/claim/clm_53C0247588B7.md)
- 2021-07-30 to 2021-10-29 | total_equity | 4,825,000,000 United States dollar | superseded | [clm_5B26A930B421](/claim/clm_5B26A930B421.md)
- 2021-07-30 to 2021-10-29 | quarterly_research_and_development | 1,468,000,000 United States dollar | superseded | [clm_6D4D07D3D745](/claim/clm_6D4D07D3D745.md)
- 2021-07-30 to 2021-10-29 | quarterly_net_income | 831,000,000 United States dollar | superseded | [clm_72FD35BC2F8B](/claim/clm_72FD35BC2F8B.md)
- 2021-07-30 to 2021-10-29 | total_assets | 122,678,000,000 United States dollar | superseded | [clm_A6E279A2371B](/claim/clm_A6E279A2371B.md)
- 2021-07-30 to 2021-10-29 | cash_and_equivalents | 11,719,000,000 United States dollar | superseded | [clm_C04364C52A43](/claim/clm_C04364C52A43.md)
- 2021-07-30 to 2021-10-29 | quarterly_revenue | 26,122,000,000 United States dollar | superseded | [clm_C1A0CF03E075](/claim/clm_C1A0CF03E075.md)
- 2021-10-29 to 2022-04-29 | quarterly_operating_income | 1,349,000,000 United States dollar | superseded | [clm_0D9A850A6915](/claim/clm_0D9A850A6915.md)
- 2021-10-29 to 2022-04-29 | quarterly_research_and_development | 1,417,000,000 United States dollar | superseded | [clm_125612CCA11E](/claim/clm_125612CCA11E.md)
- 2021-10-29 to 2022-01-28 | cash_and_equivalents | 22,406,000,000 United States dollar | superseded | [clm_24CFCD20E8FB](/claim/clm_24CFCD20E8FB.md)
- 2021-10-29 to 2022-01-28 | total_assets | 135,677,000,000 United States dollar | superseded | [clm_3A78E8CAB806](/claim/clm_3A78E8CAB806.md)
- 2021-10-29 to 2022-01-28 | total_equity | 8,954,000,000 United States dollar | superseded | [clm_47776B1A79D2](/claim/clm_47776B1A79D2.md)
- 2021-10-29 to 2022-04-29 | quarterly_revenue | 28,394,000,000 United States dollar | superseded | [clm_4E7DB80B32FD](/claim/clm_4E7DB80B32FD.md)
- 2021-10-29 to 2022-04-29 | quarterly_net_income | 3,843,000,000 United States dollar | superseded | [clm_831C3EB9EC50](/claim/clm_831C3EB9EC50.md)

## 2022

- 2022-01-28 to 2022-04-29 | total_equity | -1,685,000,000 United States dollar | superseded | [clm_059821028448](/claim/clm_059821028448.md)
- 2022-01-28 to 2023-02-03 | revenue | 101,197,000,000 United States dollar | superseded | [clm_6F29A97F7E8E](/claim/clm_6F29A97F7E8E.md)
- 2022-01-28 to 2023-02-03 | operating_income | 4,659,000,000 United States dollar | superseded | [clm_ABD7D090EBBE](/claim/clm_ABD7D090EBBE.md)
- 2022-01-28 to 2023-02-03 | research_and_development | 2,577,000,000 United States dollar | superseded | [clm_AD51107989D3](/claim/clm_AD51107989D3.md)
- 2022-01-28 to 2023-02-03 | net_income | 5,563,000,000 United States dollar | superseded | [clm_CA5A977235CC](/claim/clm_CA5A977235CC.md)
- 2022-01-28 to 2022-04-29 | cash_and_equivalents | 9,477,000,000 United States dollar | superseded | [clm_F604AF201D80](/claim/clm_F604AF201D80.md)
- 2022-01-28 to 2022-04-29 | total_assets | 92,735,000,000 United States dollar | superseded | [clm_FE4D6B1847E6](/claim/clm_FE4D6B1847E6.md)
- 2022-04-29 to 2022-07-29 | total_equity | -2,462,000,000 United States dollar | superseded | [clm_36BDCD2FA564](/claim/clm_36BDCD2FA564.md)
- 2022-04-29 to 2022-07-29 | quarterly_research_and_development | 681,000,000 United States dollar | superseded | [clm_545397327320](/claim/clm_545397327320.md)
- 2022-04-29 to 2022-07-29 | quarterly_net_income | 1,072,000,000 United States dollar | superseded | [clm_8A8B705387C8](/claim/clm_8A8B705387C8.md)
- 2022-04-29 to 2022-07-29 | quarterly_revenue | 26,116,000,000 United States dollar | superseded | [clm_AD5CD29E3A3C](/claim/clm_AD5CD29E3A3C.md)
- 2022-04-29 to 2022-07-29 | quarterly_operating_income | 1,550,000,000 United States dollar | superseded | [clm_D1800BADDE20](/claim/clm_D1800BADDE20.md)
- 2022-04-29 to 2022-07-29 | total_assets | 88,406,000,000 United States dollar | superseded | [clm_D9C91504358A](/claim/clm_D9C91504358A.md)
- 2022-04-29 to 2022-07-29 | cash_and_equivalents | 6,654,000,000 United States dollar | superseded | [clm_F11D0CB09A9B](/claim/clm_F11D0CB09A9B.md)
- 2022-07-29 to 2022-10-28 | total_assets | 88,775,000,000 United States dollar | superseded | [clm_0B64CDAF5779](/claim/clm_0B64CDAF5779.md)
- 2022-07-29 to 2022-10-28 | quarterly_net_income | 511,000,000 United States dollar | superseded | [clm_18DFB85E3679](/claim/clm_18DFB85E3679.md)
- 2022-07-29 to 2022-10-28 | total_equity | -2,860,000,000 United States dollar | superseded | [clm_7A8350CA64CA](/claim/clm_7A8350CA64CA.md)
- 2022-07-29 to 2022-10-28 | quarterly_operating_income | 1,270,000,000 United States dollar | superseded | [clm_93243511A39D](/claim/clm_93243511A39D.md)
- 2022-07-29 to 2022-10-28 | quarterly_revenue | 26,425,000,000 United States dollar | superseded | [clm_C73C975866DE](/claim/clm_C73C975866DE.md)
- 2022-07-29 to 2022-10-28 | cash_and_equivalents | 5,507,000,000 United States dollar | superseded | [clm_D603E0611309](/claim/clm_D603E0611309.md)
- 2022-07-29 to 2022-10-28 | quarterly_research_and_development | 626,000,000 United States dollar | superseded | [clm_EC8F150AAB60](/claim/clm_EC8F150AAB60.md)
- 2022-10-28 to 2023-05-05 | quarterly_net_income | 245,000,000 United States dollar | superseded | [clm_0F416935087F](/claim/clm_0F416935087F.md)
- 2022-10-28 to 2023-05-05 | quarterly_operating_income | 1,762,000,000 United States dollar | superseded | [clm_412ACECD0932](/claim/clm_412ACECD0932.md)
- 2022-10-28 to 2023-02-03 | total_assets | 85,172,000,000 United States dollar | superseded | [clm_51E2285C8CBB](/claim/clm_51E2285C8CBB.md)
- 2022-10-28 to 2023-05-05 | quarterly_revenue | 24,721,000,000 United States dollar | superseded | [clm_561577F4E516](/claim/clm_561577F4E516.md)
- 2022-10-28 to 2023-05-05 | quarterly_research_and_development | 677,000,000 United States dollar | superseded | [clm_65EEC82EAE4E](/claim/clm_65EEC82EAE4E.md)
- 2022-10-28 to 2023-02-03 | total_equity | -3,469,000,000 United States dollar | superseded | [clm_EC4CED6C3E6A](/claim/clm_EC4CED6C3E6A.md)
- 2022-10-28 to 2023-02-03 | cash_and_equivalents | 4,909,000,000 United States dollar | superseded | [clm_FDCD9ADAE5AE](/claim/clm_FDCD9ADAE5AE.md)

## 2023

- 2023-02-03 to 2023-11-03 | total_assets | 89,611,000,000 United States dollar | superseded | [clm_0BB58AF5CC26](/claim/clm_0BB58AF5CC26.md)
- 2023-02-03 to 2024-02-02 | net_income | 2,442,000,000 United States dollar | superseded | [clm_8CB43E6A8295](/claim/clm_8CB43E6A8295.md)
- 2023-02-03 to 2023-11-03 | total_equity | -3,122,000,000 United States dollar | superseded | [clm_8F011FB12C79](/claim/clm_8F011FB12C79.md)
- 2023-02-03 to 2024-02-02 | revenue | 102,301,000,000 United States dollar | superseded | [clm_9C93DDD7DFC6](/claim/clm_9C93DDD7DFC6.md)
- 2023-02-03 to 2024-02-02 | research_and_development | 2,779,000,000 United States dollar | superseded | [clm_AACAED5D5C8B](/claim/clm_AACAED5D5C8B.md)
- 2023-02-03 to 2024-02-02 | operating_income | 5,771,000,000 United States dollar | superseded | [clm_CA678F9B1053](/claim/clm_CA678F9B1053.md)
- 2023-02-03 to 2023-11-03 | cash_and_equivalents | 8,607,000,000 United States dollar | superseded | [clm_DD2196BFBA79](/claim/clm_DD2196BFBA79.md)
- 2023-05-05 to 2023-08-04 | quarterly_operating_income | 1,069,000,000 United States dollar | superseded | [clm_31410F3805B6](/claim/clm_31410F3805B6.md)
- 2023-05-05 to 2023-08-04 | quarterly_research_and_development | 688,000,000 United States dollar | superseded | [clm_4E141E39B8A3](/claim/clm_4E141E39B8A3.md)
- 2023-05-05 to 2023-08-04 | quarterly_revenue | 20,922,000,000 United States dollar | superseded | [clm_D641D3CA339B](/claim/clm_D641D3CA339B.md)
- 2023-05-05 to 2023-08-04 | quarterly_net_income | 583,000,000 United States dollar | superseded | [clm_DFBBB3A32C32](/claim/clm_DFBBB3A32C32.md)
- 2023-08-04 to 2023-11-03 | quarterly_research_and_development | 705,000,000 United States dollar | superseded | [clm_1C8AA3660F1C](/claim/clm_1C8AA3660F1C.md)
- 2023-08-04 to 2023-11-03 | quarterly_operating_income | 1,165,000,000 United States dollar | superseded | [clm_306345E16931](/claim/clm_306345E16931.md)
- 2023-08-04 to 2023-11-03 | quarterly_revenue | 22,934,000,000 United States dollar | superseded | [clm_567D24C1C834](/claim/clm_567D24C1C834.md)
- 2023-08-04 to 2023-11-03 | quarterly_net_income | 462,000,000 United States dollar | superseded | [clm_B90755901D9E](/claim/clm_B90755901D9E.md)
- 2023-11-03 to 2024-05-03 | quarterly_research_and_development | 692,000,000 United States dollar | superseded | [clm_1D16CC18543A](/claim/clm_1D16CC18543A.md)
- 2023-11-03 to 2024-02-02 | total_assets | 83,264,000,000 United States dollar | superseded | [clm_20657BC4CF27](/claim/clm_20657BC4CF27.md)
- 2023-11-03 to 2024-05-03 | quarterly_net_income | 1,006,000,000 United States dollar | superseded | [clm_3266D4A39F16](/claim/clm_3266D4A39F16.md)
- 2023-11-03 to 2024-02-02 | cash_and_equivalents | 8,298,000,000 United States dollar | superseded | [clm_53213FA0E393](/claim/clm_53213FA0E393.md)
- 2023-11-03 to 2024-05-03 | quarterly_revenue | 22,251,000,000 United States dollar | superseded | [clm_6A41894BB135](/claim/clm_6A41894BB135.md)
- 2023-11-03 to 2024-02-02 | total_equity | -2,664,000,000 United States dollar | superseded | [clm_9C911F1A8A17](/claim/clm_9C911F1A8A17.md)
- 2023-11-03 to 2024-05-03 | quarterly_operating_income | 1,486,000,000 United States dollar | superseded | [clm_CEBCD262D0A9](/claim/clm_CEBCD262D0A9.md)

## 2024

- 2024-02-02 to 2025-01-31 | research_and_development | 2,801,000,000 United States dollar | superseded | [clm_1115933822AF](/claim/clm_1115933822AF.md)
- 2024-02-02 to 2025-01-31 | operating_income | 5,211,000,000 United States dollar | superseded | [clm_247FA52D54C4](/claim/clm_247FA52D54C4.md)
- 2024-02-02 to 2024-05-03 | total_assets | 82,089,000,000 United States dollar | superseded | [clm_58646878A833](/claim/clm_58646878A833.md)
- 2024-02-02 to 2025-01-31 | net_income | 3,211,000,000 United States dollar | superseded | [clm_76055953C0AC](/claim/clm_76055953C0AC.md)
- 2024-02-02 to 2025-01-31 | revenue | 88,425,000,000 United States dollar | superseded | [clm_79C6B59B8567](/claim/clm_79C6B59B8567.md)
- 2024-02-02 to 2024-05-03 | cash_and_equivalents | 7,366,000,000 United States dollar | superseded | [clm_9E85DC873AE2](/claim/clm_9E85DC873AE2.md)
- 2024-02-02 to 2024-05-03 | total_equity | -2,404,000,000 United States dollar | superseded | [clm_BB3E1854EE81](/claim/clm_BB3E1854EE81.md)
- 2024-05-03 to 2024-08-02 | total_equity | -2,822,000,000 United States dollar | superseded | [clm_0560C3026175](/claim/clm_0560C3026175.md)
- 2024-05-03 to 2024-08-02 | quarterly_revenue | 22,244,000,000 United States dollar | superseded | [clm_6F41382B135F](/claim/clm_6F41382B135F.md)
- 2024-05-03 to 2024-08-02 | quarterly_operating_income | 920,000,000 United States dollar | superseded | [clm_923EABB7E638](/claim/clm_923EABB7E638.md)
- 2024-05-03 to 2024-08-02 | quarterly_net_income | 960,000,000 United States dollar | superseded | [clm_B3546A65B690](/claim/clm_B3546A65B690.md)
- 2024-05-03 to 2024-08-02 | quarterly_research_and_development | 763,000,000 United States dollar | superseded | [clm_CBD26E9D3AC3](/claim/clm_CBD26E9D3AC3.md)
- 2024-05-03 to 2024-08-02 | total_assets | 80,190,000,000 United States dollar | superseded | [clm_DCC8416DDC39](/claim/clm_DCC8416DDC39.md)
- 2024-05-03 to 2024-08-02 | cash_and_equivalents | 5,830,000,000 United States dollar | superseded | [clm_FBBE0148F589](/claim/clm_FBBE0148F589.md)
- 2024-08-02 to 2024-11-01 | quarterly_operating_income | 1,342,000,000 United States dollar | superseded | [clm_47588A7C0BE7](/claim/clm_47588A7C0BE7.md)
- 2024-08-02 to 2024-11-01 | quarterly_revenue | 25,026,000,000 United States dollar | superseded | [clm_5B482B8B6B87](/claim/clm_5B482B8B6B87.md)
- 2024-08-02 to 2024-11-01 | total_assets | 82,687,000,000 United States dollar | superseded | [clm_68D6D1249F43](/claim/clm_68D6D1249F43.md)
- 2024-08-02 to 2024-11-01 | cash_and_equivalents | 4,550,000,000 United States dollar | superseded | [clm_80E2FC4CFC79](/claim/clm_80E2FC4CFC79.md)
- 2024-08-02 to 2024-11-01 | total_equity | -2,894,000,000 United States dollar | superseded | [clm_C08558017D89](/claim/clm_C08558017D89.md)
- 2024-08-02 to 2024-11-01 | quarterly_research_and_development | 780,000,000 United States dollar | superseded | [clm_E52431ADC19E](/claim/clm_E52431ADC19E.md)
- 2024-08-02 to 2024-11-01 | quarterly_net_income | 846,000,000 United States dollar | superseded | [clm_EAB579090261](/claim/clm_EAB579090261.md)
- 2024-11-01 to 2025-05-02 | quarterly_net_income | 1,132,000,000 United States dollar | superseded | [clm_84A611CCE095](/claim/clm_84A611CCE095.md)
- 2024-11-01 to 2025-05-02 | quarterly_research_and_development | 745,000,000 United States dollar | superseded | [clm_8B5956C36216](/claim/clm_8B5956C36216.md)
- 2024-11-01 to 2025-01-31 | total_assets | 81,951,000,000 United States dollar | superseded | [clm_9ECBE953F1D0](/claim/clm_9ECBE953F1D0.md)
- 2024-11-01 to 2025-05-02 | quarterly_operating_income | 1,668,000,000 United States dollar | superseded | [clm_C08E8E39FE08](/claim/clm_C08E8E39FE08.md)
- 2024-11-01 to 2025-01-31 | cash_and_equivalents | 5,225,000,000 United States dollar | superseded | [clm_CF7EE5875F59](/claim/clm_CF7EE5875F59.md)
- 2024-11-01 to 2025-05-02 | quarterly_revenue | 24,366,000,000 United States dollar | superseded | [clm_F328EC96FAC9](/claim/clm_F328EC96FAC9.md)
- 2024-11-01 to 2025-01-31 | total_equity | -2,285,000,000 United States dollar | superseded | [clm_F460526043AE](/claim/clm_F460526043AE.md)

## 2025

- 2025-01-31 to 2026-01-30 | research_and_development | 3,061,000,000 United States dollar | superseded | [clm_2FE2D22FB5D0](/claim/clm_2FE2D22FB5D0.md)
- 2025-01-31 to 2026-01-30 | revenue | 95,567,000,000 United States dollar | superseded | [clm_3526E02CC404](/claim/clm_3526E02CC404.md)
- 2025-01-31 to 2025-05-02 | cash_and_equivalents | 3,633,000,000 United States dollar | superseded | [clm_5E361466F879](/claim/clm_5E361466F879.md)
- 2025-01-31 to 2025-05-02 | total_equity | -1,482,000,000 United States dollar | superseded | [clm_725ED1B8CA37](/claim/clm_725ED1B8CA37.md)
- 2025-01-31 to 2026-01-30 | operating_income | 6,237,000,000 United States dollar | superseded | [clm_8D5CA04A31D9](/claim/clm_8D5CA04A31D9.md)
- 2025-01-31 to 2026-01-30 | net_income | 4,592,000,000 United States dollar | superseded | [clm_8E6489FB6E4C](/claim/clm_8E6489FB6E4C.md)
- 2025-01-31 to 2025-05-02 | total_assets | 79,746,000,000 United States dollar | superseded | [clm_BA0CB40FEEFE](/claim/clm_BA0CB40FEEFE.md)
- 2025-05-02 to 2025-08-01 | quarterly_research_and_development | 808,000,000 United States dollar | superseded | [clm_0B1E66280A38](/claim/clm_0B1E66280A38.md)
- 2025-05-02 to 2025-08-01 | cash_and_equivalents | 7,700,000,000 United States dollar | superseded | [clm_1ECE11AF53C1](/claim/clm_1ECE11AF53C1.md)
- 2025-05-02 to 2025-08-01 | total_equity | -3,024,000,000 United States dollar | superseded | [clm_5B628692D48C](/claim/clm_5B628692D48C.md)
- 2025-05-02 to 2025-08-01 | total_assets | 86,869,000,000 United States dollar | superseded | [clm_A071ADC373FC](/claim/clm_A071ADC373FC.md)
- 2025-05-02 to 2025-08-01 | quarterly_revenue | 23,378,000,000 United States dollar | superseded | [clm_EBD577CE426C](/claim/clm_EBD577CE426C.md)
- 2025-05-02 to 2025-08-01 | quarterly_net_income | 965,000,000 United States dollar | superseded | [clm_EEB1AA6C200D](/claim/clm_EEB1AA6C200D.md)
- 2025-08-01 to 2025-10-31 | quarterly_operating_income | 1,773,000,000 United States dollar | superseded | [clm_0174D4ADB735](/claim/clm_0174D4ADB735.md)
- 2025-08-01 to 2025-10-31 | quarterly_research_and_development | 785,000,000 United States dollar | superseded | [clm_0E08BB34246F](/claim/clm_0E08BB34246F.md)
- 2025-08-01 to 2025-10-31 | total_equity | -2,766,000,000 United States dollar | superseded | [clm_19D4E7741839](/claim/clm_19D4E7741839.md)
- 2025-08-01 to 2025-10-31 | quarterly_net_income | 1,164,000,000 United States dollar | superseded | [clm_5CE45C375310](/claim/clm_5CE45C375310.md)
- 2025-08-01 to 2025-10-31 | total_assets | 89,176,000,000 United States dollar | superseded | [clm_955B71BEDF5A](/claim/clm_955B71BEDF5A.md)
- 2025-08-01 to 2025-10-31 | cash_and_equivalents | 8,145,000,000 United States dollar | superseded | [clm_D324AE99FB7B](/claim/clm_D324AE99FB7B.md)
- 2025-08-01 to 2025-10-31 | quarterly_revenue | 29,776,000,000 United States dollar | superseded | [clm_F3747D6BBBD0](/claim/clm_F3747D6BBBD0.md)
- 2025-10-31 to 2026-01-30 | total_assets | 87,479,000,000 United States dollar | superseded | [clm_3612243D03E4](/claim/clm_3612243D03E4.md)
- 2025-10-31 to 2026-05-01 | quarterly_operating_income | 2,119,000,000 United States dollar | superseded | [clm_5E95567E88D7](/claim/clm_5E95567E88D7.md)
- 2025-10-31 to 2026-05-01 | quarterly_net_income | 1,548,000,000 United States dollar | superseded | [clm_A2515A3F5DA8](/claim/clm_A2515A3F5DA8.md)
- 2025-10-31 to 2026-01-30 | total_equity | -2,620,000,000 United States dollar | superseded | [clm_A5FFCDEFD45A](/claim/clm_A5FFCDEFD45A.md)
- 2025-10-31 to 2026-01-30 | cash_and_equivalents | 9,569,000,000 United States dollar | superseded | [clm_AD3FC4C60348](/claim/clm_AD3FC4C60348.md)
- 2025-10-31 to 2026-05-01 | quarterly_revenue | 27,005,000,000 United States dollar | superseded | [clm_E98452D4EC19](/claim/clm_E98452D4EC19.md)
- 2025-10-31 to 2026-05-01 | quarterly_research_and_development | 752,000,000 United States dollar | superseded | [clm_F44401F3D74A](/claim/clm_F44401F3D74A.md)
- 2025-11-24 | cfo | David Kennedy | valid | [clm_2C3CDF485EF7](/claim/clm_2C3CDF485EF7.md)

## 2026

- 2026-01-30 | net_income | 5,936,000,000 United States dollar | valid | [clm_151D6D325FE9](/claim/clm_151D6D325FE9.md)
- 2026-01-30 to 2026-05-01 | cash_and_equivalents | 11,528,000,000 United States dollar | superseded | [clm_1621178DAB02](/claim/clm_1621178DAB02.md)
- 2026-01-30 | research_and_development | 3,142,000,000 United States dollar | valid | [clm_2F35293C362B](/claim/clm_2F35293C362B.md)
- 2026-01-30 | operating_income | 8,149,000,000 United States dollar | valid | [clm_8EA0FD1BA4AF](/claim/clm_8EA0FD1BA4AF.md)
- 2026-01-30 to 2026-05-01 | total_equity | -2,470,000,000 United States dollar | superseded | [clm_BF26BF255F1C](/claim/clm_BF26BF255F1C.md)
- 2026-01-30 | revenue | 113,538,000,000 United States dollar | valid | [clm_CE17328FA94F](/claim/clm_CE17328FA94F.md)
- 2026-01-30 to 2026-05-01 | total_assets | 101,286,000,000 United States dollar | superseded | [clm_EC5D91EBEAEF](/claim/clm_EC5D91EBEAEF.md)
- 2026-05-01 to 2026-07-31 | total_equity | -1,404,000,000 United States dollar | superseded | [clm_69F9D9C5BC56](/claim/clm_69F9D9C5BC56.md)
- 2026-05-01 to 2026-07-31 | total_assets | 114,913,000,000 United States dollar | superseded | [clm_73C6B038E715](/claim/clm_73C6B038E715.md)
- 2026-05-01 to 2026-07-31 | quarterly_net_income | 3,438,000,000 United States dollar | superseded | [clm_A755B9DA4904](/claim/clm_A755B9DA4904.md)
- 2026-05-01 to 2026-07-31 | quarterly_operating_income | 3,656,000,000 United States dollar | superseded | [clm_AC8474A69402](/claim/clm_AC8474A69402.md)
- 2026-05-01 to 2026-07-31 | quarterly_revenue | 43,842,000,000 United States dollar | superseded | [clm_B7400D076924](/claim/clm_B7400D076924.md)
- 2026-05-01 to 2026-07-31 | quarterly_research_and_development | 983,000,000 United States dollar | superseded | [clm_CE4B5569FDCD](/claim/clm_CE4B5569FDCD.md)
- 2026-05-01 to 2026-07-31 | cash_and_equivalents | 11,578,000,000 United States dollar | superseded | [clm_DDC88FD68782](/claim/clm_DDC88FD68782.md)
- 2026-07-31 | quarterly_net_income | 4,133,000,000 United States dollar | valid | [clm_057C37E4EDE0](/claim/clm_057C37E4EDE0.md)
- 2026-07-31 | quarterly_research_and_development | 1,109,000,000 United States dollar | valid | [clm_3DC5E6471FE9](/claim/clm_3DC5E6471FE9.md)
- 2026-07-31 | cash_and_equivalents | 11,569,000,000 United States dollar | valid | [clm_7CCFCAC11FE4](/claim/clm_7CCFCAC11FE4.md)
- 2026-07-31 | quarterly_operating_income | 5,385,000,000 United States dollar | valid | [clm_916E3952E961](/claim/clm_916E3952E961.md)
- 2026-07-31 | quarterly_revenue | 46,971,000,000 United States dollar | valid | [clm_D04D3016F44C](/claim/clm_D04D3016F44C.md)
- 2026-07-31 | total_equity | -1,427,000,000 United States dollar | valid | [clm_D8C98F2E570E](/claim/clm_D8C98F2E570E.md)
- 2026-07-31 | total_assets | 127,393,000,000 United States dollar | valid | [clm_F95D06804FEC](/claim/clm_F95D06804FEC.md)
---

AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.